Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
PRF Technologies Ltd. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
PRFX
Nasdaq
2834
www.painreform.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for PRF Technologies Ltd.
PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI-Driven Energy Platforms
- Jul 27th, 2026 6:30 am
PRF Technologies to Showcase GridFeed™ at Energy Trading Week Europe 2026
- Jul 21st, 2026 6:30 am
PRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across Solar and Energy Storage Assets
- Jul 15th, 2026 7:15 am
PRF Technologies’ DeepSolar Successfully Validates Predict™ AI Platform for Renewable Energy Revenue Optimization Using Real-World European Market Data
- Jul 8th, 2026 6:30 am
PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark
- Jun 25th, 2026 6:30 am
Top Premarket Gainers
- May 29th, 2026 5:16 am
PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy Markets
- May 28th, 2026 6:30 am
PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study
- May 26th, 2026 6:30 am
EXCLUSIVE: PRF Technologies Advances Drop-Less Drug For Cataract Surgery Pain
- Apr 30th, 2026 8:31 pm
PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial
- Apr 28th, 2026 6:00 am
PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms
- Mar 27th, 2026 6:00 am
PRF Technologies Ltd. Announces Commercial Collaboration Agreement with Blade Ranger to Accelerate Large-Scale DeepSolar Commercial Engagements
- Mar 17th, 2026 6:30 am
PRF Technologies’ DeepSolar Announces its First Commercial Due Diligence Engagement with EDF Power Solutions Israel, a Global Leader in Renewable Energy
- Feb 18th, 2026 7:15 am
PRF Technologies Wins Another European Utility-Scale Solar Deployment, Expanding DeepSolar’s Installed Commercial Base
- Feb 11th, 2026 6:30 am
PRF Technologies Files Its First Patent Application for Solar Plant Micro-Climate Forecast Modeling Designed to Improve Energy Production Forecast Accuracy
- Jan 20th, 2026 7:05 am
PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy Platforms
- Jan 15th, 2026 2:05 pm
PainReform’s LayerBio’s Drop-Less OcuRing™-K Delivery Platform Demonstrates Favorable Safety Profile in Preclinical and Phase I Clinical Studies
- Jan 12th, 2026 7:00 am
PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market
- Jan 5th, 2026 7:00 am
BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability Week
- Dec 30th, 2025 6:48 am
PainReform Confirms the Ability of Its LayerBio Drop-Less Sustained-Release Ocular Platform to Accommodate Multiple Drug Entities
- Dec 10th, 2025 6:30 am
Scroll